Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lead poisoning: case studies.

J N Gordon1, A Taylor, P N Bennett

  • 1Medicine and Laboratory Services, Royal United Hospital, Combe Park, Bath BA1 3NG, UK.

British Journal of Clinical Pharmacology
|May 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ubiquitin and ubiquitin conjugates in human lens.

Experimental eye research·1992
Same author

Evidence for increased prevalence of SRY mutations in XY females with complete rather than partial gonadal dysgenesis.

American journal of human genetics·1992
Same author

Systemic distribution of wear debris after hip replacement. A cause for concern?

The Journal of bone and joint surgery. British volume·1992
Same author

Estimates of HIV infection among injecting drug users in Glasgow, 1985-1990.

AIDS (London, England)·1992
Same author

The classification of afferents from muscle spindles of the jaw-closing muscles of the cat.

The Journal of physiology·1992
Same author

The effect of succinylcholine on cat gastrocnemius muscle spindle afferents of different types.

The Journal of physiology·1992
Same journal

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

British journal of clinical pharmacology·2026
Same journal

Comparative risk of ventricular arrhythmia and sudden cardiac death among acetylcholinesterase inhibitors in dementia: A population-based cohort study.

British journal of clinical pharmacology·2026
Same journal

Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus.

British journal of clinical pharmacology·2026
Same journal

Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study.

British journal of clinical pharmacology·2026
Same journal

Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs.

British journal of clinical pharmacology·2026
Same journal

Case-malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy.

British journal of clinical pharmacology·2026
See all related articles

Early lead toxicity symptoms are vague, making occupational history crucial for diagnosis. Blood lead levels, though a common marker, can stay high for years due to bone redistribution, impacting treatment decisions.

Area of Science:

  • Toxicology
  • Environmental Health
  • Occupational Medicine

Background:

  • Early clinical features of lead toxicity are often non-specific, necessitating a thorough occupational history.
  • Lead in the body is distributed between blood (t1/2 35 days) and bone/dentine (t1/2 20-30 years).
  • Elevated blood lead concentrations can persist long after exposure cessation due to bone redistribution.

Observation:

  • Blood lead concentration is the primary biomarker for inorganic lead exposure.
  • Zinc protoporphyrin (ZPP) concentration offers insight into lead exposure over the preceding three months.
  • Symptomatic patients require chelation therapy with sodium calciumedetate and succimer, or dimercaprol for lead encephalopathy.

Findings:

  • Blood lead concentration serves as the most utilized marker for inorganic lead exposure.

Related Experiment Videos

  • Zinc protoporphyrin (ZPP) levels effectively indicate lead exposure within the last three months.
  • Treatment protocols vary based on symptom presentation and blood lead levels, ranging from succimer alone to combined chelation therapies.

    • Implications:

    • Understanding lead's long-term bone burden is critical for managing chronic toxicity.
    • Accurate assessment of lead exposure through biomarkers like ZPP aids in timely and appropriate treatment.
    • Tailored therapeutic strategies, including specific chelating agents, are essential for effectively managing lead poisoning based on clinical status.